**2. Epidemiology**

The cicatricial alopecia constitutes 3.2–7.3% of the hair loss [7, 10, 20]. The majority of cicatricial alopecia is PCA, and lymphocyte-predominant diseases are the most common subgroup of PCA, and female patients are more affected than men [20]. The most common subtypes of lymphocytic pre-dominant PCA are pseudopelade of Brocq, LPP, discoid lupus erythematosus (DLE) [10, 20]. Although it is mostly seen on the scalp, it can involve other facial and body areas [5].

### **3. Primary cicatricial alopecia**

PCA is characterized by increased inflammation around the 'bulge' area of the hair follicle and causes irreversible damage to the epithelial stem cells of the hair follicle. It destroys the remodeling, cycling and regenerative capacity of the hair follicle, and finally causes irreversible hair loss [7, 9, 10].

The NAHRS has classified PCA based on the predominant type of inflammatory cell on hair follicle biopsy; lymphocyte-predominant subgroup, neutrophilpredominant subgroup, mixed subgroup and non-specific subgroup (**Table 1**) [7, 9].

The general characteristics of PCA subgroups are summarized in **Table 2** [4, 6, 7, 9, 10, 21–25].

#### **3.1 Management of primary cicatricial alopecia**

Management of PCA is diagnostically and therapeutically challenging due to progression to permanent hair loss. The most important step is informing the patient about the aims of treatment and providing realistic expectations. The successful management of PCA can be achieved with early diagnosis and appropriate treatment to decrease inflammation and progression to scarring alopecia [7, 9]. For this purpose, clinical, histological and laboratory findings should be carefully examined.

#### *3.1.1 Clinical assessment*

Patients with PCA may present various distributions of an acute or gradual onset of symptoms. Although some cases are asymptomatic, common symptoms include



#### **Table 2.**

*The general characteristics of PCA.*

itching, pain, burning, irritation and discharge on the affected areas. A complete and careful history should include age, ethnic and family origin, nutrition, psychosocial condition, onset and progression of symptoms, medical disorders including autoimmune and inflammatory diseases, infections, malignancies, trauma, burns, radiation, surgeries and hair care practice (hot combs, excess traction, shampoo, drugs, injections) [5, 7, 9].

Careful physical examination of the affected skin with the aid of a magnifying lens or scalp dermoscopy, also defined as "tricoscopy", in a well-lit environment is essential. PCA is characterized clinically by the lack of visible follicular ostia and the presence of scarring and alopecia. Symptoms of inflammation of the affected area are often indicative of active disease; erythema, scaling, hyperkeratotic plugs, pustules, crusting, scalp bogginess, and different colored dots seen by trichoscopy (**Figure 1**). The epidermal atrophy, irregularly spaced hair shafts, multiple hairs tufts and positive pull test of the anagen hair shaft are other findings of physical examination [5, 7, 9, 26].

During clinical examination, taken digital photography and virtual documentation allows high-speed analysis of prognosis and response to treatment, and facilitates archiving. Additionally, it is like evidence in legal problems.

#### *3.1.2 Laboratory tests*

Complete blood count (CBC), serum levels of iron, zinc, folate, vitamin B-12, thyroid-stimulating hormone (TSH) and estrogen should be evaluated. The serum levels of total testosterone, free testosterone and dehydroepiandrosterone sulfate are useful for diagnosis and differential diagnosis of androgenetic alopecia.

#### **Figure 1.**

*26-years-old male patient has severe dissecting cellulitis with inflammatory plaques, nodules and discharges purulent material on the scalp.*

### *3.1.3 Histological assessment*

A biopsy is always recommended in the assessment of cicatricial alopecia. It can be useful to confirm clinic impression and scarring, identify the underlying pathology and specific type, help guide management and ultimately establishes realistic treatment goals. Samples should be taken using a 4 mm punch biopsy orientated parallel to the angle of the hair shaft growth and deep enough to include the entire HF at the margin of the active disease. Two biopsies are recommended for horizontal and vertical sections. PCA is characterized histopathologically by variable degrees of inflammation of hair follicle epithelium, the replacement of hair follicle structures with scar-like fibrous tissue and hyalinization of surrounding collagen [5–7, 9].

#### **3.2 Treatment**

The principal aim of the treatment of PCA is to reduce symptoms and inflammation, slow down and if possible stop the progression of the disease at the earliest phase, and prevent irreversible alopecia [4, 7, 9].

A clear consensus on successful treatments has not yet been achieved in clinical practice. However, immunosuppressants such as potent topical, intralesional and oral

#### *Surgical Management of Scarring Alopecia DOI: http://dx.doi.org/10.5772/intechopen.107323*

corticosteroids and antimalarials drugs (hydroxychloroquine) are useful for lymphocyte-predominant lesions; antimicrobials (tetracyclines) and dapsone are useful for the neutrophil predominant lesions [4, 7]. Additionally, it is very important to monitor the course and activity of the disease, and response to treatment with regular dermoscopy and clinical examination [26].

Some pharmacological agents such as topical minoxidil and oral finasteride are also used in the treatment. Although controversial and with several side effects including minoxidil-induced telogen effluvium, skin irritation and itching; topical minoxidil can be useful by stimulating vascularity of hair follicles for growth in some patients. Oral finasteride inhibits the enzyme 5-alpha reductase, which is involved in the conversion of testosterone to the more potent dihydrotestosterone, and provides to increase in the ratio of anagen to telogen hairs. However, it can cause erectile dysfunction, decreased libido, impotence and anxiety in men [4, 7, 10, 20].

When severe hair loss occurs, hats, hairpieces and prosthetic wigs may be useful for cosmetic camouflage. The scalp reduction surgeries by primary excisions, local flaps and tissue expansion, and hair transplantation can be used in the surgical treatment of PCA. The stability of PCA is the most important parameter for surgical hair restoration. In the presence of clinically unstable cicatricial alopecia, surgical treatment is not recommended due to the high risk of recurrence of the disease. A 2-year disease-free period is recommended before surgery to minimize the risk of disease recurrence and to increase treatment success [7]. Surgical applications in scarred alopecia are discussed in detail in the section of "secondary cicatricial alopecia".

#### **3.3 Follow-up**

PCA can be reactivated after a quiet of one or more years. Thus, close follow-up is needed for the course of the disease, its severity, response to treatment, treatmentrelated side effects and the patient's psychological and social problems with regular dermatoscopic and clinical examination [26].

### **4. Seconder cicatricial alopecia**

SCA develops due to the result of an underlying process or an external agent. The destruction of the hair follicle is not the primary pathological event, generalized disruption of the skin and skin appendages results in scarring and irreversible hair loss [1, 3, 7, 18, 27].

Potential etiological factors are granulomatous and autoimmune diseases, infections, neoplastic processes and physical agents (physical trauma, ionizing radiation, burn, previous surgeries) (**Table 1**, **Figures 2** and **3**) [1–3, 11, 13–19, 27, 28].

#### **4.1 Management of seconder cicatricial alopecia**

The most important step in treatment for SCA is the selection of the right patient and mature scar. The patient's expectations should be investigated, and the patient should be informed about procedures, complications, and follow-up period [16].

#### **Figure 2.**

*A 33-years-old male patient presented with malignant head and neck tumor (a). After 1 year of radiotherapy, radiation-induced irreversible scarring alopecia observes on the left face and scalp areas.*

**Figure 3.** *A 31-years-old female patient presents post-burn scarring alopecia on the bilateral eyebrows.*

### *4.1.1 Clinical and laboratory assessment*

The patients should be evaluated for age, sex, etiology, previous medical and surgical treatment, medical conditions with laboratory tests including CBC, blood chemistry panel, coagulation panel, viral serology, localization and dimensions of scarring alopecia, scar characteristics and availability of donor hair for restoration.

Evaluation of scar characteristics is also very important for the management of SCA. The scars should be fully mature that pale, soft, flat, and flexible with sufficient subcutaneous soft tissue and vascular supply [14–16]. If the scar is immature, hypertrophic or excessively atrophic, and located on directly muscle, bone or tendon with not enough subcutaneous tissue, various approaches including preoperative fat grafting, stem cell and laser treatment and combinations could be used to increase the quality, pliability and vascularity of scar tissue [2, 12, 15, 29–32].

#### **4.2 Treatment of seconder cicatricial alopecia**

Various medical and surgical procedures have been determined to camouflage and reconstruct scarring alopecia depending on size, location, type of alopecia; laxity, quality, vascular supply of recipient skin and donor hair availability [1–3, 11–14, 16, 28, 29, 33, 34].

#### *4.2.1 Non-surgical camouflage and medical treatment*

Prosthetic wigs, tattoo micro-pigmentation, colored spray, dye and make-up can be used for non-surgical camouflage of scalp cicatricle alopecia, but not natural and available for facial scarring alopecia [14, 28, 29, 33].

Some medical management that scar-less ointment, silicone pomade and sheeting, laser treatment, fat injection, *platelet-rich plasma* (PRP) and stem cells can be used for scar treatment and maturity, but alopecia cannot be treated [15, 28–31].

#### *4.2.2 Surgical treatment*

Reconstruction of post-burn scarring alopecia is challenging because of permanent hair loss, scar stiffness and poor vascularity, so need to camouflage and removing by surgical procedures [13, 14, 16, 35].

#### *4.2.2.1 Surgical excision*

The primary and staged scar excisions are simple methods for correcting small scarring alopecia, but not available for large defects, and scar widening due to secondary tension can be cause relapse [3, 14, 16, 28, 33].

The scar reduction with tissue expansion can be used to avoid relapse and reconstruction of large scarring alopecia. However, increases surgical stage and treatment period, expander-related complications that tissue necrosis, seroma formation, nerve damage and infection; unnatural hair growth direction, facial disfiguring during balloon expansion and a visible scar on expander margins are the main disadvantages [3, 13, 14, 16, 17, 28, 33, 36].

Composite scalp grafts, pedicle and free scalp flap can be used for scarring alopecia, but graft failure in the poor vascular recipient area, increased hair density, unnatural direction of hair, surgery-related scar and complications, microvascular dissection and anastomosis are the main limitations of these techniques [13, 14].

#### *4.2.2.2 Autologous hair transplantation*

Otology hair transplantation, that redistributes existing hair follicle units (FUs) to recipient areas, seems to be the most effective technique for scarring alopecia [2, 3, 11–16, 19, 28, 29, 34, 35, 37]. However, poor vascularity and scar stiffness are challenging problem for graft viability [2, 14, 15] and increases post-transplantation complication such as infection, tissue ischemia and necrosis [1, 3, 12, 14–16, 28]. Thus, mechanical and vascular characteristics of scar tissue can be improved by laser, fat injection and stem cell treatments, and combination of them to obtain successful result before hair transplantation [2, 12, 14, 15, 29–32].

Adipose tissue has a volume-increasing effect and includes adipose-derived stem cells (ADSCs) that have a primary role in the regenerative purposes of skin and

subcutaneous tissue by increasing angiogenesis and new collagen deposition [15, 18, 29, 31]. Using autologous fat grafts increase pliability, vascularity and maturity of scar tissues, and fills the loss of volume in depressed scars [2, 12, 14–16, 29–31]. In addition, fat grafts can be prepared rich in stem cells and combined with laser, PRP and other treatments [15, 18, 30].

The FUs can be harvested in ellipse tissue strips from donor areas that follicular unit transplantation (FUT) technique or individually FU with micro-punch that FUE technique. FUT technique has some disadvantages. It causes a permanent scars in donor areas, it is not usefull for patients with tight scalp tissue and other body parts (beard, chest, axilla, pubis), it is not available to harvest only single-hair FUs, and it needs more assistance for procedures [3, 14, 16, 19, 35, 37, 38].

FUE is a strategy for graft harvest with different kind's punches with quick healing donor areas without a linear and conspicuous scar [12, 14–16, 29, 34, 35, 37, 38]. It is first-choice method for hair transplants due to the ability to individually choosing of desirable FUs, with minimal spot scarring and no suturing [11, 14, 16, 34].

#### *4.2.2.2.1 Technique detail of FUE hair transplantation*

Care should be taken to plan implantation with the correct direction and shaping of hair graft to achieve a good cosmetic result. FUE hair transplantation can be performed under local anesthesia with or without sedation. The number of implantation channels and density of FUs (grafts/cm2 ) for scar camouflage should be determined by the environment unaffected hair-bearing area or opposite healthy face before surgery.

a) Selection of donor side

Post-auricular and occipital scalp are the most common donor areas for hair transplantations, due to genetically stable and most resistant to hormone-related alopecia [16, 28]. Hair follicles in the scalp grow in groups of one to four hairs, so it is important to choose single-haired follicles for restoration of scarring alopecia on the eyebrows, eyelashes, mustache, beard and hairline of the scalp (**Figure 4**) [35]. Two to more hair-FUs grafts may be used toward the center of the mustache and beard alopecia to improve density but can result in unnatural aesthetic appearances,

#### **Figure 4.**

*The image shows 1, 2, 3 and 4-hair follicular units on the right to left (a, b, c, d). While each follicular unit has a single hair in hair-bearing aesthetic subunits of the face, it has one to four hairs on the scalp.*

especially with a short beard and mustache [16]. Additionally, single-hair FUs have a small size with low metabolic requirements [13, 19], thus, it is also a good option for graft viability in scarring alopecia.

The submandibular beards are the best donor areas with the natural caliber and density for mustache, beard and side-burn scarring alopecia, which have similar hair characteristics. The availability of submandibular beard hair is sometimes a limiting factor, but FUE offers the advantage of harvesting different body hair such as the occipital and post-auricular scalp, suprapubic and other body [2, 14, 16, 37]. However, heterotopic hair transplantation can cause different regrowth duration and physiological cycle, color change by aging, and different calibration and density due to different anatomic and physiological characteristics [14, 28].

b) Anesthesia and harvesting hair follicles

The donor's hairs are cut to 2–3 mm lengths before procedures. With the patient in the supine position, on the operating table, donor and recipient sites are anesthetized by infraorbital, supraorbital, supratrochlear, mental, cervical, post-auricular or occipital nerve block. Then donor area infiltration anesthesia is performed by the tumescent solution that a mixture of 0.9% saline, 2% lidocaine, and 1:1000 epinephrine. Tumescent with low concentration or without epinephrine is injected in the recipient area, to avoid decreased subdermal blood supply due to vasoconstriction [14, 15, 19, 28, 34].

The FUs are harvested from the donor area individually by using handled or low rotational speed electronic micro-motor powered 4–5 mm-length and 0.6–1.2 mmdiameter circular micro-punch to avoid transection of follicles. Single-hair FUs are selected from the occipital and post-auricular scalp for restoration of scalp hairline and facial hair. The micro forceps are used to apply gentle pressure on the skin around the FUs graft, elevating it lightly to allow the top part of the graft to be grasped. The extracted FUs are handled gently and kept moist in sterile petri-dish with 0.9% saline or special solutions at 4°C until transplantation [14–16, 28, 34].

c) Implanting hair follicles

Single channels are opened for each graft and FUs are synchronously implanted into the pre-made channel by using micro forceps. Channeling in fibrotic scar area is performed by using 0.75–1.2 mm width and 4–5 mm length classic micro blade or sapphire blade to make incisions perpendicular parallel to the growth direction of existing hair with similar density of opposite side or environment of scarring alopecia [11, 14, 15, 19, 34].

Attention must be paid for making true channeling and hair transplantation with surrounding facial hair without neurovascular injuries.

d) Discharge

Oral antibiotics and analgesics are administered for 5 postoperative days. Recipient and donor areas left open without occlusive dressing, with daily antibiotic ointment and washing with hair lotion or shampoo after the third postoperative day. Patients should be followed for at least 12 months. Folliscope examination is useful to evaluate the condition and density of transplanted FU [3, 15]. After transplantation, PRP injection can be used to improve graft viability [18].

#### *4.2.2.2.2 Post transplantation complications*

The most important complications of cicatricial alopecias include graft failure, infection, tissue ischemia and necrosis after surgery because of additional vascular injury during close and deep channel opening and graft implantations [14].

#### *4.2.2.2.3 Survival rate and density of transplanted follicle units*

The most important determining factor of surgery success is the survival rate of transplanted FUs in scarring alopecia. The survival rate of transplanted FUs grafts is over 90% in healthy vascularized areas [16, 19], but there is confusion about various survival rates (0–90%) for scarring alopecia [14].

In the scarring alopecia, Shao et al. [3] obtained a mean of 78.96% (ranged from 64.29 to 95.00) surviving FU density. Meyer-Gonzalez and Bisanga [37] considered more than 80% graft survival successful. Yoo et al. [1] obtained a mean 80.67% (ranged from 70% to 90%) survival rate with significant satisfaction. In the literature, an average 80% or over of graft viability has been accepted as success in scarring alopecia [1, 19, 37].

Low graft viability is a challenging problem due to poorly vascularized and fibrotic recipient areas [1, 2, 12, 14, 16, 28]. Various treatment methods are used to increase scar vascularity and maturity before hair transplantation. Akdag et el. [2] transferred fat grafts and FUs to scarring alopecia after cleft lip surgery at 3 months intervals, and an average of 82% (73.6–88.6) graft viability was obtained. Agaoglu et al. [15] combined non-ablative fractional laser and cryopreserved microfat grafting multistage before hair transplantation, and obtained a mean of 85.04% (76–95) graft viability. Podda et al. [32] performed cold-ablative Er:YAG Laser-Assisted hair transplantation and obtain apparent 95% graft survival. Autologous fat grafting, includes adiposederived regenerative cells that have a primary role in the regenerative purposes by secreting a number of growth factors, increasing local neovascularization, collagen and elastin synthesis, and improving texture, thickness, pliability and angiogenesis of scar tissues [2, 15, 29, 30, 39].

During the treatment of scarring alopecia, one of the most difficult decisions is to determine the density of FUs. Because low blood supply is limited to high-density transplantation in scarring alopecia. While average follicle density for normal scalp alopecia is accepted over 30–35 FU grafts per cm<sup>2</sup> [1, 16], but there was no consensus about scarring alopecia.

Barr and Barrera [16] recommended 20–30 FUs/cm2 scarring alopecia according to scar characteristics. Unger et al. [28] recommended a transplantation density of 30 FU/ cm2 or less to prevent the development of postoperative complications; 15–20 FU/cm2 for scarring alopecia with poor blood supply; 20–30 FU/cm2 for scarring alopecia with better perfusion. Wang et al obtained 30–34 grafts/cm2 graft density and averaged 97% graft survival (range 87–100%) in scarring alopecia at 1-year follow-up. Civas et al. transplanted about 24.9 FU/cm2 in scarring alopecia with 86.7% satisfactory result of the patient. As a general rule, there is a decrease in graft survival when the graft frequency exceeds 30 FU/cm2 in scarring alopecia areas. While small and mature scars can be transplanted in a close to normal number (30 FUs/cm2 ) since nutrition will be good; however, low-density transplantation and if required staged transplantation is recommended for large and problematic scars [16, 28].

#### *4.2.2.3 Staged hair transplantation*

After hair transplant in scarring alopecia, normal perfusion and oxygenation during the ischemia-reperfusion period and re-vascularization of hair follicle grafts mainly affect graft viability. If transplanted grafts are not re-vascularized within a few days after surgery, the graft will go failure [15, 16]. Additionally, the number of transplanted FUs determines the rate of graft survival. If too many grafts are transplanted in a small area, they compete for reduced blood flow through the scar

tissue and low blood flow cannot meet grafts' nutrition. Assuming that there is acceptable blood perfusion, it is recommended that this number does not exceed 30 grafts/cm<sup>2</sup> when performing a hair transplant in scarring alopecia. For this reason, it is better to perform multistage hair transplantation than running the risk of complications [16].
